Abstract:Objective: The problems and challenges encountered by Chinese medical institutions in implementing the national centralized drug procurement was investigated and analyzed in order to provide reference for the regulatory agencies to formulate policies. Methods: A questionnaire survey was conducted to collect the problems encountered by 329 Chinese medical institutions in implementing the national centralized drug procurement and the corresponding suggestions provided by relevant experts. Statistical analysis was performed to identify differences in the themes and the number of collected problems, further revealing the relevance to the region in which the medical institutions is located. Result: 1360 problems and suggestions were collected from 329 Chinese medical institutions that located in North (19.15%), Northeast (5.78%), East (33.43%), Central (10.03%), South (9.73%), Southwest (14.89%), and Northwest China (6.99%). There was statistically significant difference in the number of collected problems and suggestions between regions ( p < 0.001). Furthermore, the content of gathered problems and suggestions involves in 15 themes including system construction, organizational system and work responsibilities, reasonable measurement and reporting of procurement volume et al. These themes that these medical institutions are focusing on are mainly centered on the supply guarantee (15%), reasonable measurement and reporting of procurement volume (11.40%) and guarantee measures for clinical priority use (9.48%) of drugs with national centralized procurement. Meanwhile, we found that problems regarding the supply guarantee of drugs with national centralized procurement displayed significant difference between regions ( p = 0.0096). Conclusion: Chinese medical institutions are facing great challenges in implementing the national centralized drug procurement. The scientific study and judgment of the current situation and the construction of corresponding solution require a precise classification of the problems encountered by medical institutions in the process of implementing the national centralized drug procurement policy, which is of great practical significance for deepening the reform of the medical and health system.

Analysis of provincial centralized bidding and procurement of drugs in China

A comparative analysis of centralized drug procurement in China

Analysis and discussion on the pharmaceutical centralized procurement implementation — a case study of a large provincial hospital in China

Comparative Study on Essential Drug Centralized Bidding Purchase Plans of Provinces in China

Comparative Analysis of Drug Bidding and Purchasing Mode at Home and Abroad

Assessment and Rational Thinking of "bidding Group"in Chinese Centralized Drug Procurement System

Problems and challenges encountered by Chinese medical institutions in implementing the national centralized drug procurement

Retrospective study on drug’s centralized purchasing system of healthcare institutions in China

Centralized Procurement of Anticancer Drugs at Provincial Level in China

Critical thinking and analysis of procurement of drugs with target quantity in Shanghai

Influencing Mechanism of Generics Quality Consistency Evaluation on Bidding and Grouping Method of Centralized Drug Procurement System in China

Structure of economic and technical indicator in centralized bidding procurement of essential medicines in China

Analysis on the Bidding Drug Prices and Its Sale-permission in the Centralized Bidding of Essential Drug in Sichuan Province in 2011

Analysis of Current Situation and Countermeasures of Drug Supply Chain of Centralized Procurement in China

The Analysis of the Framework Building and Current Implementation Status of Centralized Bidding and Purchasing of National Essential Medicine System

The Development and Thinking of Drug Centralized Procurement Policy in China

Commentary on Regular Pattern of Purchaser Setting in Centralized Drug Bidding and Purchase Mechanism:Experiences of European Union Countries Based on Different Health Care System

PNS40 The Implementation of Volume-Based Drug Procurement Policy in China

Impact and implications of national centralized drug procurement in China

Influencing factors of quantity-based pricing in the essential medicines’ centralized bidding procurement in China

Preliminary exploration on"bidding group"in medical supplies procurement system